📱 Send Us a Text Message! We’d love to hear from you! Please include your name and email address so we can reply. Don’t worry — this won’t sign you up for our email list. We’ll only use your info to respond to your question.In this episode of Reset Recharge, Dr. Komal Patil-Sisodia explores a groundbreaking study that reveals how menopause hormone therapy (MHT) may actually reduce the risk of type 2 diabetes in perimenopausal women with prediabetes.Dr. Komal unpacks the data from a major Diabetes and Metabolism study of over 6,500 women aged 46–60, showing that those who used hormone therapy were 30% less likely to develop diabetes. She explains the science behind how estrogen supports metabolic health — improving insulin sensitivity, lowering inflammation, reducing central fat gain, and supporting pancreatic function — and why timing, age, BMI, and ethnicity make all the difference.You’ll learn:How estrogen affects blood sugar and fat distributionWhy MHT works best when started near menopauseWhich hormone formulations and delivery routes are safest and most effectiveWhy personalized, evidence-based care is key to menopause medicineWhether you’re navigating perimenopause, supporting patients, or simply curious about hormone health, this episode breaks down complex science into practical takeaways you can use.💡 Key takeaway: Menopause hormone therapy isn’t just about symptom relief — it can be metabolic protection for the right woman, at the right time.Connect with me:TikTokInstagramEastside Menopause & MetabolismTime Stamps:00:00 – 00:54 | Welcome & Episode Overview  00:55 – 02:30 | The Study That Sparked the Conversation  02:31 – 04:00 | Who Benefits Most from Hormone Therapy  04:01 – 06:00 | How Estrogen Supports Metabolic Health  06:01 – 07:45 | The Timing Hypothesis Explained  07:46 – 09:15 | Type & Route of Hormone Therapy Matter  09:16 – 10:45 | Balancing Benefits and Risks  10:46 – 12:15 | The Takeaway: Personalized Menopause Care  12:16 – 13:06 | Closing & Next StepsReferences:Shih YH, Yang CY, Wang SJ, Lung CC. Menopausal hormone therapy decreases the likelihood of diabetes development in peri‑menopausal individuals with prediabetes. Diabetes Metab. 2024 Jul;50(4):101546. doi: 10.1016/j.diabet.2024.101546. Epub 2024 Jun 5. PMID: 38843591.Thanks for listening. Find more info about Reset Recharge on the website or Instagram.

Ver todos los episodios